Frequency and clinical impact of hyperkalaemia within a large, modern, real-world heart failure population.
Joseph B MuhlesteinJennifer KammererTami L BairKirk U KnowltonViet T LeJeffrey L AndersonDonald L LappéHeidi T MayPublished in: ESC heart failure (2020)
In this large, real-world HF population, HK was common and linked to baseline clinical risk factors, declining use of RAASi treatment, and an increase in future MACE, regardless of baseline LVEF. Both HK and reduced RAASi use were independent predictors of future MACE.